Prevalencia de retinopatía diabética en la ciudad de Badajoz 2002 (Proyecto Extremadura para prevención de la ceguera)

  1. E. Santos-Bueso
  2. C. Fernández-Pérez
  3. A. Macarro
  4. J.A. Fernandez-Vigo
Revista:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Ano de publicación: 2007

Volume: 82

Número: 3

Páxinas: 153-158

Tipo: Artigo

DOI: 10.4321/S0365-66912007000300007 DIALNET GOOGLE SCHOLAR lock_openAcceso aberto editor

Outras publicacións en: Archivos de la Sociedad Española de Oftalmologia

Resumo

Objective: To establish the prevalence of diabetic retinopathy (DR), types and risk factors in a diabetic population in the city of Badajoz. Methods: A cross-sectional study, with prospective data collection, was performed in 2002 on 762 randomly selected diabetic patients belonging to two Primary Care Centers. We evaluated age, gender, type, treatment, duration of diabetes and blood pressure levels. Two color fundus photographs were taken and ophthalmoscopy performed on both eyes. Data were analyzed using SPSS (11.5). Results: The mean age of the patients was 66.2 (DS 11.4) years, 4.7% were type 1 diabetics, 29% were insulin-treated and 52.8% had elevated blood pressure. Prevalence of DR was 29.8%, macular edema 1.4% and proliferative DR 4.8%. Multivariate analysis showed that patients with an evolution of between 5 and 10 years had a frequency 1.13 times higher (ORaj 1.13; IC 95% 0.68-1.88; p=0.648) than those of less than 5 years evolution, while those with more than 15 years evolution had a frequency 3.12 times higher (ORaj 3.12; IC 95% 1.85-5.26; p<0.001). Patients receiving treatment with oral antidiabetic agents had an RD prevalence 2.39 times higher (ORaj 2.39; IC 95% 1.21-4.74; p=0,012) than those treated with diet only. Patients treated with insulin had a 10.32 higher frequency (ORaj 10.32; IC 95% 5.07-21.00; p<0.001) than those treated with diet. Conclusions: 29.8% of the diabetic population in the city of Badajoz is affected by DR. Although this prevalence is lower than that observed in previous studies performed by the same team, further studies should be carried out to detect risk sub-groups to allow us to act to decrease such a high prevalence.

Referencias bibliográficas

  • Santos-Bueso, E, Fernández-Vigo, J, Fernández-Pérez, C, Macarro Merino, A, Fernández Perianes, J. (2005). Prevalencia de retinopatía diabética en la Comunidad Autónoma de Extremadura: 1997-2001 (Proyecto Extremadura para prevención de la ceguera). Arch Soc Esp Oftalmol. 80. 187-194
  • Henricsson, M, Nystrom, L, Blohme, G, Ostman, J, Kullberg, C, Svensson, M. (2003). The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 26. 349-354
  • Larsson, LI, Alm, A, Bergenheim, T, Lithner, F, Bergstrom, R. (1999). Retinopathy in diabetic patients aged 15-50 years in the county of Umea, Sweden. Acta Ophthalmol. 77. 430-436
  • Karamanos, B, Porta, M, Songini, M, Metelko, Z, Kerenyi, Z, Tamas, G. (2000). Different risk factors of microangiopahty in patients with type I diabetes mellitus of short versus long duration: The EURODIAB IDDM Complications Study. Diabetologia. 43. 348-355
  • Stratton, IM, Kohner, EM, Aldington, SJ, Turner, RC, Holman, RR, Manley, SE. (2001). UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 44. 156-163
  • Wong, TY, Cruickshank, KJ, Klein, R, Klein, BE, Moss, SE, Palta, M. (2002). HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology. 109. 275-281
  • Porta, M, Sjoelie, AK, Chaturvedi, N, Stevens, L, Rottiers, R, Veglio, M. (2001). Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia. 44. 2203-2209
  • (1991). Early Treatment Diabetic Retinopathy Study design and baseline patients characteristics: ETDRS report number 7. Ophthalmology. 98. 741-756
  • Fernández-Vigo, J, Sanchez Macho, J, Diaz Rey, A, Barros, J, Tomé, M, Bueno, J. (1993). The prevalence of diabetic retinopathy in northwest Spain: An epidemiological study of diabetic retinopathy in Galicia. I. Acta Ophthalmol. 71. 22-26
  • Martín, C, Fernández-Vigo, J, Fernández, J, Díaz, AJ, Montero, I, Molina, M. (1992). Prevalencia de Retinopatía Diabética: estudio comparativo de dos poblaciones no seleccionadas en Galicia y Extremadura. Arch Soc Esp Oftalmol. 62. 389-394
  • Romero Aroca, P, Del Castillo Dejardín, D. (1996). Estudio de prevalencia de retinopatía diabética en la población del Baix Camp (Tarragona). Arch Soc Esp Oftalmol. 71. 261-268
  • Esteban Ortega, MM, Rodríguez Hurtado, F, Jiménez Moleón, JJ, Bueno Cavanillas, A. (1999). Prevalencia de retinopatía en diabéticos de más de diez años de evolución en la zona Norte de Granada. Arch Soc Esp Oftalmol. 74. 137-144
  • López, IM, Diez, A, Velilla, S, Rueda, A, Álvarez, A, Pastor, CJ. (2002). Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol. 9. 205-214
  • Goldaracena, MB, Escudero, JM, Arrondo, A, Villarrubia, A, Aramendia, B, Iturralde, R. (1998). Prevalencia de retinopatía diabética en una población diabética registrada en atención primaria. Arch Soc Esp Oftalmol. 73. 263-268
  • Jerneld, B. (1988). Prevalence of diabetic retinopathy: A population study from the swedish Island of Gotland. Acta Ophthalmol. 66. 3-32
  • Henricsson, M, Groop, L, Heijl, A. (1996). Progression of retinopathy is related to glycaemic control even in patients with mild diabetes mellitus. Acta Ophthamol. 74. 528-532
  • Sjolie, AK. (1985). Ocular complications in insulin treated diabetes mellitus: An epidemiological study. Acta Ophthalmol. 172. 1-77
  • Mitchell, P, Smith, W, Wang, JJ, Attebo, K. (1998). Prevalence of diabetic retinopathy in an older community: The Blue Mountains Eye Study. Ophthalmology. 105. 406-411
  • Klein, R, Klein, BE, Moss, SE, Davis, MD, DeMets, DL. (1984). The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 102. 520-526
  • Klein, R, Klein, BE, Moss, SE, Davis, MD, DeMets, DL. (1984). The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 102. 527-532